Health Optimization Index
Ketogenic Diet
- Nick’s assessment
- Promising
- Research evidence
- A, strong evidence
- Attention
- 24.1 / 100▲ Rising this week
BioHarmony score
Ketogenic diets reliably induce nutritional ketosis within days and can improve glycemic control in medically supervised type 2 diabetes programs, but long-term weight loss often converges with low-fat diets and cardiovascular response is highly individual. The strongest clinical niche remains refractory pediatric epilepsy and supervised metabolic disease care, not broad wellness use.
Read the full report Benefits, risks and practical guidance.
Read Nick’s assessment Why it earned this rating
Ketogenic Diet is a 6.5–7.0/10 fit for people using metabolic health, blood sugar, and body composition as a measured nutrition experiment. The body-composition signal is real: Leung GKW et al. 2025 pooled 33 randomized trials and found lower weight and body-fat measures. The counterweight is just as important. Amini MR et al. 2024 found no meaningful blood-pressure improvement, and Gardner CD et al. 2018 showed healthy low-carb was not superior to healthy low-fat for 12-month weight loss. Ketogenic Diet can help the right responder, especially with glucose tracking, but Ketogenic Diet is not automatically better than a well-built whole-food plan. Use Ketogenic Diet when the target is measurable, the tradeoff is acceptable, and adherence is realistic.
✅ Best for: Adults with type 2 diabetes using a clinician-supervised low-carb program with medication adjustment and nutrient monitoring; children with drug-resistant epilepsy under pediatric neurology and dietitian care; adults using keto as an 8-12 week elimination or metabolic-reset diet; hyperandrogenic PCOS women tracking cycles, insulin, and androgen markers; APOE3 cognitive-aging users trying MCT-heavy or Mediterranean-keto variants; and ultra-endurance athletes who have completed a 12+ week adaptation block. Use ApoB, thyroid, sex hormones, glucose, insulin, symptoms, and adherence as decision gates.
❌ Avoid if: You take SGLT2 inhibitors unless a specialist explicitly supervises the transition; you have T1D without intensive ketone and glucose monitoring; you are pregnant or lactating; you have active eating disorder history, pancreatitis, liver failure, or suspected fatty-acid oxidation disorder; you have a family history of unexplained metabolic crises, exercise collapse, or Reye-like episodes; or you are a lean active woman whose thyroid, SHBG, free sex hormones, sleep, menstrual function, or training output worsens. Also avoid chronic saturated-fat-heavy keto if ApoB rises.
Share your experience
Your answers are optional and help other readers — they never change my score. How community input works.
One step left: confirm it’s you
New voice here? We send a one-tap verification link so every entry comes from a real person. Signed-in members skip this.
Make a 12-month prediction Will it rise or fall in the Index?
Choose a direction and your confidence. Correct predictions earn leaderboard points.
Your prediction is final once submitted. We’ll check it in 12 months. See the leaderboard →